Current Knowledge and Future Perspectives of Exosomes as Nanocarriers in Diagnosis and Treatment of Diseases

References

• Martin JD, Cabral H, Stylianopoulos T, Jain RK. Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges. Nat Rev Clin Oncol. 2020;17(4):251–266. doi:10.1038/s41571-019-0308-z
   PubMed Web of Science ®Google Scholar
• Dangkoub F, Sankian M, Tafaghodi M, Jaafari MR, Badiee A. The impact of nanocarriers in the induction of antigen-specific immunotolerance in autoimmune diseases. J Control Release. 2021;339:274–283. doi:10.1016/j.jconrel.2021.09.037
   PubMed Web of Science ®Google Scholar
• Alyautdin R, Khalin I, Nafeeza MI, Haron MH, Kuznetsov D. Nanoscale drug delivery systems and the blood-brain barrier. Int J Nanomed. 2014;9:795–811. doi:10.2147/IJN.S52236
   PubMed Web of Science ®Google Scholar
• Mao L, Wu W, Wang M, et al. Targeted treatment for osteoarthritis: drugs and delivery system. Drug Deliv. 2021;28(1):1861–1876. doi:10.1080/10717544.2021.1971798
   PubMed Web of Science ®Google Scholar
• Crommelin DJA, van Hoogevest P, Storm G. The role of liposomes in clinical nanomedicine development. What now? Now what? J Control Release. 2020;318:256–263. doi:10.1016/j.jconrel.2019.12.023
   PubMed Web of Science ®Google Scholar
• Cabral H, Miyata K, Osada K, Kataoka K. Block copolymer micelles in nanomedicine applications. Chem Rev. 2018;118(14):6844–6892. doi:10.1021/acs.chemrev.8b00199
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Imaoka T, Tanabe M, Kambe T. New horizon of nanoparticle and cluster catalysis with dendrimers. Chem Rev. 2020;120(2):1397–1437. doi:10.1021/acs.chemrev.9b00188
   PubMed Web of Science ®Google Scholar
• Wang TT, Xia YY, Gao JQ, Xu DH, Han M. Recent progress in the design and medical application of in situ self-assembled polypeptide materials. Pharmaceutics. 2021;13(5):753. doi:10.3390/pharmaceutics13050753
   PubMed Web of Science ®Google Scholar
• Song S, Qin Y, He Y, et al. Functional nanoprobes for ultrasensitive detection of biomolecules. Chem Soc Rev. 2010;39(11):4234–4243. doi:10.1039/c000682n
   PubMed Web of Science ®Google Scholar
• Long Z, Wu Y-P, Gao H-Y, et al. Functionalization of halloysite nanotubes via grafting of dendrimer for efficient intracellular delivery of siRNA. Bioconjug Chem. 2018;29(8):2606–2618. doi:10.1021/acs.bioconjchem.8b00321
   PubMed Web of Science ®Google Scholar
• Pulskamp K, Diabaté S, Krug HF. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol Lett. 2007;168(1):58–74. doi:10.1016/j.toxlet.2006.11.001
   PubMed Web of Science ®Google Scholar
• Akçan R, Aydogan HC, Yildirim M, Taştekin B, Sağlam N. Nanotoxicity: a challenge for future medicine. Turk J Med Sci. 2020;50(4):1180–1196. doi:10.3906/sag-1912-209
   PubMed Web of Science ®Google Scholar
• Sun D, Zhuang X, Zhang S, et al. Exosomes are endogenous nanoparticles that can deliver biological information between cells. Adv Drug Deliv Rev. 2013;65(3):342–347. doi:10.1016/j.addr.2012.07.002
   PubMed Web of Science ®Google Scholar
• Luan X, Sansanaphongpricha K, Myers I, et al. Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin. 2017;38(6):754–763. doi:10.1038/aps.2017.12
   PubMed Web of Science ®Google Scholar
• Ailuno G, Baldassari S, Lai F, Florio T, Caviglioli G. Exosomes and extracellular vesicles as emerging theranostic platforms in cancer research. Cells. 2020;9(12):2569. doi:10.3390/cells9122569
   PubMed Web of Science ®Google Scholar
• He C, Zheng S, Luo Y, Wang B. Exosome theranostics: biology and translational medicine. Theranostics. 2018;8(1):237–255. doi:10.7150/thno.21945
   PubMed Web of Science ®Google Scholar
• Díaz-Garrido N, Badia J, Baldomà L. Microbiota-derived extracellular vesicles in interkingdom communication in the gut. J Extracell Vesicles. 2021;10(13):e12161. doi:10.1002/jev2.12161
   PubMed Web of Science ®Google Scholar
• Li YJ, Wu JY, Liu J, et al. Artificial exosomes for translational nanomedicine. J Nanobiotechnol. 2021;19(1):242. doi:10.1186/s12951-021-00986-2
   PubMed Web of Science ®Google Scholar
• Qambrani A, Rehman FU, Tanziela T, et al. Biocompatible exosomes nanodrug cargo for cancer cell bioimaging and drug delivery. Biomed Mater. 2021;16(2):025026. doi:10.1088/1748-605X/abaaa2
   PubMed Web of Science ®Google Scholar
• Liang Y, Duan L, Lu J, Xia J. Engineering exosomes for targeted drug delivery. Theranostics. 2021;11(7):3183–3195. doi:10.7150/thno.52570
   PubMed Web of Science ®Google Scholar
• Patel S, Schmidt KF, Farhoud M, et al. In vivo tracking of [(89)Zr]Zr-labeled engineered extracellular vesicles by PET reveals organ-specific biodistribution based upon the route of administration. Nucl Med Biol. 2022;112–113:20–30. doi:10.1016/j.nucmedbio.2022.06.004
   PubMed Web of Science ®Google Scholar
• Gupta D, Liang X, Pavlova S, et al. Quantification of extracellular vesicles in vitro and in vivo using sensitive bioluminescence imaging. J Extracell Vesicles. 2020;9(1):1800222. doi:10.1080/20013078.2020.1800222
   PubMed Web of Science ®Google Scholar
• Wiklander OP, Nordin JZ, O’Loughlin A, et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles. 2015;4:26316. doi:10.3402/jev.v4.26316
   PubMed Web of Science ®Google Scholar
• Matsumoto A, Takahashi Y, Nishikawa M, et al. Role of phosphatidylserine-derived negative surface charges in the recognition and uptake of intravenously injected B16BL6-derived exosomes by macrophages. J Pharm Sci. 2017;106(1):168–175. doi:10.1016/j.xphs.2016.07.022
   PubMed Web of Science ®Google Scholar
• Yan F, Zhong Z, Wang Y, et al. Exosome-based biomimetic nanoparticles targeted to inflamed joints for enhanced treatment of rheumatoid arthritis. J Nanobiotechnol. 2020;18(1):115. doi:10.1186/s12951-020-00675-6
   PubMed Web of Science ®Google Scholar
• Cheng L, Zhang X, Tang J, Lv Q, Liu J. Gene-engineered exosomes-thermosensitive liposomes hybrid nanovesicles by the blockade of CD47 signal for combined photothermal therapy and cancer immunotherapy. Biomaterials. 2021;275:120964. doi:10.1016/j.biomaterials.2021.120964
   PubMed Web of Science ®Google Scholar
• Hade MD, Suire CN, Suo Z. An effective peptide-based platform for efficient exosomal loading and cellular delivery of a microRNA. ACS Appl Mater Interfaces. 2023;15(3):3851–3866. doi:10.1021/acsami.2c20728
   PubMed Web of Science ®Google Scholar
• Hao R, Yu Z, Du J, et al. A high-throughput nanofluidic device for exosome nanoporation to develop cargo delivery vehicles. Small. 2021;17(35):e2102150. doi:10.1002/smll.202102150
   PubMed Web of Science ®Google Scholar
• Ilahibaks NF, Ardisasmita AI, Xie S, et al. TOP-EVs: technology of protein delivery through extracellular vesicles is a versatile platform for intracellular protein delivery. J Control Release. 2023;355:579–592. doi:10.1016/j.jconrel.2023.02.003
   PubMed Web of Science ®Google Scholar
• Akbari A, Jabbari N, Sharifi R, et al. Free and hydrogel encapsulated exosome-based therapies in regenerative medicine. Life Sci. 2020;249:117447. doi:10.1016/j.lfs.2020.117447
   PubMed Web of Science ®Google Scholar
• Niemczyk-Soczynska B, Zaszczyńska A, Zabielski K, Sajkiewicz SP. Electrospun and composite materials for bone/cartilage and neural tissue engineering. Materials. 2021;14(22):6899. doi:10.3390/ma14226899
   PubMed Web of Science ®Google Scholar
• Kang Y, Xu J, Meng L, et al. 3D bioprinting of dECM/Gel/QCS/nHAp hybrid scaffolds laden with mesenchymal stem cell-derived exosomes to improve angiogenesis and osteogenesis. Biofabrication. 2023;15(2):024103. doi:10.1088/1758-5090/acb6b8
   Web of Science ®Google Scholar
• Dai J, Su Y, Zhong S, et al. Exosomes: key players in cancer and potential therapeutic strategy. Signal Transduct Target Ther. 2020;5(1):145. doi:10.1038/s41392-020-00261-0
   PubMed Web of Science ®Google Scholar
• Fan W-J, Liu D, Pan L-Y, et al. Exosomes in osteoarthritis: updated insights on pathogenesis, diagnosis, and treatment. Front Cell Dev Biol. 2022;10:949690. doi:10.3389/fcell.2022.949690
   PubMed Web of Science ®Google Scholar
• Gharavi AT, Hanjani NA, Movahed E, Doroudian M. The role of macrophage subtypes and exosomes in immunomodulation. Cell Mol Biol Lett. 2022;27(1):83. doi:10.1186/s11658-022-00384-y
   PubMed Web of Science ®Google Scholar
• Shen Q, Huang Z, Yao J, Jin Y. Extracellular vesicles-mediated interaction within intestinal microenvironment in inflammatory bowel disease. J Adv Res. 2022;37:221–233. doi:10.1016/j.jare.2021.07.002
   PubMed Web of Science ®Google Scholar
• Li D-F, Yang M-F, Xu J, et al. Extracellular vesicles: the next generation theranostic nanomedicine for inflammatory bowel disease. Int J Nanomed. 2022;17:3893–3911. doi:10.2147/IJN.S370784
   PubMed Web of Science ®Google Scholar
• Cai Y, Zhang L, Zhang Y, Lu R. Plant-derived exosomes as a drug-delivery approach for the treatment of inflammatory bowel disease and colitis-associated cancer. Pharmaceutics. 2022;14(4):822. doi:10.3390/pharmaceutics14040822
   PubMed Web of Science ®Google Scholar
• Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 2019;8(7):727. doi:10.3390/cells8070727
   PubMed Web of Science ®Google Scholar
• Ridder K, Keller S, Dams M, et al. Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation. PLoS Biol. 2014;12(6):e1001874. doi:10.1371/journal.pbio.1001874
   PubMed Web of Science ®Google Scholar
• Skotland T, Hessvik NP, Sandvig K, Llorente A. Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology. J Lipid Res. 2019;60(1):9–18. doi:10.1194/jlr.R084343
   PubMed Web of Science ®Google Scholar
• Vlassov AV, Magdaleno S, Setterquist R, Conrad R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta. 2012;1820(7):940–948. doi:10.1016/j.bbagen.2012.03.017
   PubMed Web of Science ®Google Scholar
• Mashouri L, Yousefi H, Aref AR, et al. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol Cancer. 2019;18(1):75. doi:10.1186/s12943-019-0991-5
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu Y, Liu H, Tang WH. Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019;9(1):19. doi:10.1186/s13578-019-0282-2
   PubMed Web of Science ®Google Scholar
• Grant BD, Donaldson JG. Pathways and mechanisms of endocytic recycling. Nat Rev Mol Cell Biol. 2009;10(9):597–608. doi:10.1038/nrm2755
   PubMed Web of Science ®Google Scholar
• Stoorvogel W, Strous GJ, Geuze HJ, Oorschot V, Schwartz AL. Late endosomes derive from early endosomes by maturation. Cell. 1991;65(3):417–427. doi:10.1016/0092-8674(91)90459-C
   PubMed Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478). doi:10.1126/science.aau6977
   PubMed Web of Science ®Google Scholar
• Möbius W, Ohno-Iwashita Y, van Donselaar EG, et al. Immunoelectron microscopic localization of cholesterol using biotinylated and non-cytolytic perfringolysin O. J Histochem Cytochem. 2002;50(1):43–55. doi:10.1177/002215540205000105
   PubMed Web of Science ®Google Scholar
• Babst M, Katzmann DJ, Estepa-Sabal EJ, Meerloo T, Emr SD. Escrt-III: an endosome-associated heterooligomeric protein complex required for mvb sorting. Dev Cell. 2002;3(2):271–282. doi:10.1016/S1534-5807(02)00220-4
   PubMed Web of Science ®Google Scholar
• Wollert T, Hurley JH. Molecular mechanism of multivesicular body biogenesis by ESCRT complexes. Nature. 2010;464(7290):864–869. doi:10.1038/nature08849
   PubMed Web of Science ®Google Scholar
• Henne WM, Stenmark H, Emr SD. Molecular mechanisms of the membrane sculpting ESCRT pathway. Cold Spring Harb Perspect Biol. 2013;5(9):a016766. doi:10.1101/cshperspect.a016766
   PubMed Web of Science ®Google Scholar
• Hurley JH. ESCRTs are everywhere. EMBO J. 2015;34(19):2398–2407. doi:10.15252/embj.201592484
   PubMed Web of Science ®Google Scholar
• Raiborg C, Stenmark H. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature. 2009;458(7237):445–452. doi:10.1038/nature07961
   PubMed Web of Science ®Google Scholar
• Colombo M, Raposo G, Théry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30(1):255–289. doi:10.1146/annurev-cellbio-101512-122326
   PubMed Web of Science ®Google Scholar
• Colombo M, Moita C, van Niel G, et al. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci. 2013;126(Pt 24):5553–5565. doi:10.1242/jcs.128868
   PubMed Web of Science ®Google Scholar
• Verweij FJ, van Eijndhoven MA, Hopmans ES, et al. LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activation. EMBO J. 2011;30(11):2115–2129. doi:10.1038/emboj.2011.123
   PubMed Web of Science ®Google Scholar
• Chairoungdua A, Smith DL, Pochard P, Hull M, Caplan MJ. Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling. J Cell Biol. 2010;190(6):1079–1091. doi:10.1083/jcb.201002049
   PubMed Web of Science ®Google Scholar
• Trajkovic K, Hsu C, Chiantia S, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008;319(5867):1244–1247. doi:10.1126/science.1153124
   PubMed Web of Science ®Google Scholar
• Blanc L, Vidal M. New insights into the function of Rab GTPases in the context of exosomal secretion. Small GTPases. 2018;9(1–2):95–106. doi:10.1080/21541248.2016.1264352
   PubMedGoogle Scholar
• Hsu C, Morohashi Y, Yoshimura S, et al. Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J Cell Biol. 2010;189(2):223–232. doi:10.1083/jcb.200911018
   PubMed Web of Science ®Google Scholar
• Ostrowski M, Carmo NB, Krumeich S, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010;12(1):19–30; sup pp 11–13. doi:10.1038/ncb2000
   Web of Science ®Google Scholar
• Yokoi A, Villar-Prados A, Oliphint PA, et al. Mechanisms of nuclear content loading to exosomes. Sci Adv. 2019;5(11):eaax8849. doi:10.1126/sciadv.aax8849
   PubMed Web of Science ®Google Scholar
• S ELA, Mäger I, Breakefield XO, Wood MJ. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013;12(5):347–357. doi:10.1038/nrd3978
   PubMed Web of Science ®Google Scholar
• Mulcahy LA, Pink RC, Carter DR. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014;3:24641.
   PubMedGoogle Scholar
• van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213–228. doi:10.1038/nrm.2017.125
   PubMed Web of Science ®Google Scholar
• Cossetti C, Iraci N, Mercer TR, et al. Extracellular vesicles from neural stem cells transfer IFN-γ via Ifngr1 to activate Stat1 signaling in target cells. Mol Cell. 2014;56(2):193–204. doi:10.1016/j.molcel.2014.08.020
   PubMed Web of Science ®Google Scholar
• Parolini I, Federici C, Raggi C, et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem. 2009;284(49):34211–34222. doi:10.1074/jbc.M109.041152
   PubMed Web of Science ®Google Scholar
• Fitzner D, Schnaars M, van Rossum D, et al. Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J Cell Sci. 2011;124(Pt 3):447–458. doi:10.1242/jcs.074088
   PubMed Web of Science ®Google Scholar
• Chivet M, Javalet C, Laulagnier K, et al. Exosomes secreted by cortical neurons upon glutamatergic synapse activation specifically interact with neurons. J Extracell Vesicles. 2014;3(1):24722. doi:10.3402/jev.v3.24722
   PubMedGoogle Scholar
• Mathieu M, Martin-Jaular L, Lavieu G, Théry C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019;21(1):9–17. doi:10.1038/s41556-018-0250-9
   PubMed Web of Science ®Google Scholar
• Théry C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006;30(1):. doi:10.1002/0471143030.cb0322s30
   Google Scholar
• Langevin SM, Kuhnell D, Orr-Asman MA, et al. Balancing yield, purity and practicality: a modified differential ultracentrifugation protocol for efficient isolation of small extracellular vesicles from human serum. RNA Biol. 2019;16(1):5–12. doi:10.1080/15476286.2018.1564465
   PubMed Web of Science ®Google Scholar
• Onódi Z, Pelyhe C, Terézia Nagy C, et al. Isolation of high-purity extracellular vesicles by the combination of iodixanol density gradient ultracentrifugation and bind-elute chromatography from blood plasma. Front Physiol. 2018;9:1479. doi:10.3389/fphys.2018.01479
   PubMed Web of Science ®Google Scholar
• Dehghani M, Lucas K, Flax J, McGrath J, Gaborski T. Tangential flow microfluidics for the capture and release of nanoparticles and extracellular vesicles on conventional and ultrathin membranes. Adv Mater Technol. 2019;4(11):1900539. doi:10.1002/admt.201900539
   PubMed Web of Science ®Google Scholar
• Alvarez ML, Khosroheidari M, Kanchi Ravi R, DiStefano JK. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int. 2012;82(9):1024–1032. doi:10.1038/ki.2012.256
   PubMed Web of Science ®Google Scholar
• Ning B, Huang Z, Youngquist BM, et al. Liposome-mediated detection of SARS-CoV-2 RNA-positive extracellular vesicles in plasma. Nat Nanotechnol. 2021;16(9):1039–1044. doi:10.1038/s41565-021-00939-8
   PubMed Web of Science ®Google Scholar
• Clayton A, Court J, Navabi H, et al. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J Immunol Methods. 2001;247(1–2):163–174. doi:10.1016/S0022-1759(00)00321-5
   PubMed Web of Science ®Google Scholar
• Nakai W, Yoshida T, Diez D, et al. A novel affinity-based method for the isolation of highly purified extracellular vesicles. Sci Rep. 2016;6(1):33935. doi:10.1038/srep33935
   PubMedGoogle Scholar
• Soares Martins T, Catita J, Martins Rosa I, da Cruz e Silva OA, Henriques AG. Exosome isolation from distinct biofluids using precipitation and column-based approaches. PLoS One. 2018;13(6):e0198820. doi:10.1371/journal.pone.0198820
   PubMed Web of Science ®Google Scholar
• García-Romero N, Madurga R, Rackov G, et al. Polyethylene glycol improves current methods for circulating extracellular vesicle-derived DNA isolation. J Transl Med. 2019;17(1):75. doi:10.1186/s12967-019-1825-3
   PubMedGoogle Scholar
• Sim S-L, He T, Tscheliessnig A, et al. Protein precipitation by polyethylene glycol: a generalized model based on hydrodynamic radius. J Biotechnol. 2012;157(2):315–319. doi:10.1016/j.jbiotec.2011.09.028
   PubMed Web of Science ®Google Scholar
• Kimura T, Ferran B, Tsukahara Y, et al. Production of adeno-associated virus vectors for in vitro and in vivo applications. Sci Rep. 2019;9(1):13601. doi:10.1038/s41598-019-49624-w
   PubMedGoogle Scholar
• Ruysschaert T, Marque A, Duteyrat J-L, et al. Liposome retention in size exclusion chromatography. BMC Biotechnol. 2005;5(1):11. doi:10.1186/1472-6750-5-11
   PubMedGoogle Scholar
• Hong CS, Funk S, Muller L, Boyiadzis M, Whiteside TL. Isolation of biologically active and morphologically intact exosomes from plasma of patients with cancer. J Extracell Vesicles. 2016;5:29289. doi:10.3402/jev.v5.29289
   PubMed Web of Science ®Google Scholar
• Gámez-Valero A, Monguió-Tortajada M, Carreras-Planella L, et al. Size-exclusion chromatography-based isolation minimally alters extracellular vesicles’ characteristics compared to precipitating agents. Sci Rep. 2016;6(1):33641. doi:10.1038/srep33641
   PubMedGoogle Scholar
• Shu S, Yang Y, Allen CL, et al. Purity and yield of melanoma exosomes are dependent on isolation method. J Extracell Vesicles. 2020;9(1):1692401. doi:10.1080/20013078.2019.1692401
   PubMed Web of Science ®Google Scholar
• Lin S, Yu Z, Chen D, et al. Progress in microfluidics-based exosome separation and detection technologies for diagnostic applications. Small. 2020;16(9):e1903916. doi:10.1002/smll.201903916
   PubMed Web of Science ®Google Scholar
• Kanwar SS, Dunlay CJ, Simeone DM, Nagrath S. Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes. Lab Chip. 2014;14(11):1891–1900. doi:10.1039/C4LC00136B
   PubMed Web of Science ®Google Scholar
• Lee K, Shao H, Weissleder R, Lee H. Acoustic purification of extracellular microvesicles. ACS Nano. 2015;9(3):2321–2327. doi:10.1021/nn506538f
   PubMed Web of Science ®Google Scholar
• Contreras-Naranjo JC, Wu HJ, Ugaz VM. Microfluidics for exosome isolation and analysis: enabling liquid biopsy for personalized medicine. Lab Chip. 2017;17(21):3558–3577. doi:10.1039/C7LC00592J
   PubMed Web of Science ®Google Scholar
• Zhang N, Sun N, Deng C. Rapid isolation and proteome analysis of urinary exosome based on double interactions of Fe(3)O(4)@TiO(2)-DNA aptamer. Talanta. 2021;221:121571. doi:10.1016/j.talanta.2020.121571
   PubMed Web of Science ®Google Scholar
• Zhang P, He M, Zeng Y. Ultrasensitive microfluidic analysis of circulating exosomes using a nanostructured graphene oxide/polydopamine coating. Lab Chip. 2016;16(16):3033–3042. doi:10.1039/C6LC00279J
   PubMed Web of Science ®Google Scholar
• Wang B, Wang Y, Yan Z, Sun Y, Su C. Colorectal cancer cell-derived exosomes promote proliferation and decrease apoptosis by activating the ERK pathway. Int J Clin Exp Pathol. 2019;12(7):2485–2495.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li CW, Chan LC, et al. Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth. Cell Res. 2018;28(8):862–864. doi:10.1038/s41422-018-0060-4
   PubMed Web of Science ®Google Scholar
• Ma Z, Wei K, Yang F, et al. Tumor-derived exosomal miR-3157-3p promotes angiogenesis, vascular permeability and metastasis by targeting TIMP/KLF2 in non-small cell lung cancer. Cell Death Dis. 2021;12(9):840. doi:10.1038/s41419-021-04037-4
   PubMed Web of Science ®Google Scholar
• Liu Y, Gu Y, Han Y, et al. Tumor exosomal RNAs promote lung pre-metastatic niche formation by activating alveolar epithelial TLR3 to recruit neutrophils. Cancer Cell. 2016;30(2):243–256. doi:10.1016/j.ccell.2016.06.021
   PubMed Web of Science ®Google Scholar
• Sun H, Wang C, Hu B, et al. Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3. Signal Transduct Target Ther. 2021;6(1):187. doi:10.1038/s41392-021-00579-3
   PubMed Web of Science ®Google Scholar
• Wei Y, Lai X, Yu S, et al. Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells. Breast Cancer Res Treat. 2014;147(2):423–431. doi:10.1007/s10549-014-3037-0
   PubMed Web of Science ®Google Scholar
• Li Z, Meng X, Wu P, et al. Glioblastoma cell-derived lncRNA-containing exosomes induce microglia to produce complement C5, promoting chemotherapy resistance. Cancer Immunol Res. 2021;9(12):1383–1399. doi:10.1158/2326-6066.CIR-21-0258
   PubMed Web of Science ®Google Scholar
• Fabbri M, Paone A, Calore F, et al. MicroRNAs bind to toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A. 2012;109(31):E2110–E2116. doi:10.1073/pnas.1209414109
   PubMed Web of Science ®Google Scholar
• Frühbeis C, Fröhlich D, Kuo WP, et al. Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLoS Biol. 2013;11(7):e1001604. doi:10.1371/journal.pbio.1001604
   PubMed Web of Science ®Google Scholar
• Koniusz S, Andrzejewska A, Muraca M, et al. Extracellular vesicles in physiology, pathology, and therapy of the immune and central nervous system, with focus on extracellular vesicles derived from mesenchymal stem cells as therapeutic tools. Front Cell Neurosci. 2016;10:109. doi:10.3389/fncel.2016.00109
   PubMed Web of Science ®Google Scholar
• Guitart K, Loers G, Buck F, et al. Improvement of neuronal cell survival by astrocyte-derived exosomes under hypoxic and ischemic conditions depends on prion protein. Glia. 2016;64(6):896–910. doi:10.1002/glia.22963
   PubMed Web of Science ®Google Scholar
• Sardar Sinha M, Ansell-Schultz A, Civitelli L, et al. Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers. Acta Neuropathol. 2018;136(1):41–56. doi:10.1007/s00401-018-1868-1
   PubMed Web of Science ®Google Scholar
• Asai H, Ikezu S, Tsunoda S, et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci. 2015;18(11):1584–1593. doi:10.1038/nn.4132
   PubMed Web of Science ®Google Scholar
• Dinkins MB, Dasgupta S, Wang G, Zhu G, Bieberich E. Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer’s disease. Neurobiol Aging. 2014;35(8):1792–1800. doi:10.1016/j.neurobiolaging.2014.02.012
   PubMed Web of Science ®Google Scholar
• Kato T, Miyaki S, Ishitobi H, et al. Exosomes from IL-1β stimulated synovial fibroblasts induce osteoarthritic changes in articular chondrocytes. Arthritis Res Ther. 2014;16(4):R163. doi:10.1186/ar4679
   PubMed Web of Science ®Google Scholar
• Ni Z, Kuang L, Chen H, et al. The exosome-like vesicles from osteoarthritic chondrocyte enhanced mature IL-1β production of macrophages and aggravated synovitis in osteoarthritis. Cell Death Dis. 2019;10(7):522. doi:10.1038/s41419-019-1739-2
   PubMed Web of Science ®Google Scholar
• Wu X, Crawford R, Xiao Y, Mao X, Prasadam I. Osteoarthritic subchondral bone release exosomes that promote cartilage degeneration. Cells. 2021;10(2):251. doi:10.3390/cells10020251
   PubMed Web of Science ®Google Scholar
• Henning RJ. Cardiovascular exosomes and MicroRNAs in cardiovascular physiology and pathophysiology. J Cardiovasc Transl Res. 2021;14(2):195–212. doi:10.1007/s12265-020-10040-5
   PubMed Web of Science ®Google Scholar
• Zarin B, Rafiee L, Daneshpajouhnejad P, Haghjooy Javanmard S. A review on the role of CAFs and CAF-derived exosomes in progression and metastasis of digestive system cancers. Tumour Biol. 2021;43(1):141–157. doi:10.3233/TUB-200075
   PubMedGoogle Scholar
• Purghè B, Manfredi M, Ragnoli B, Baldanzi G, Malerba M. Exosomes in chronic respiratory diseases. Biomed Pharmacother. 2021;144:112270. doi:10.1016/j.biopha.2021.112270
   PubMed Web of Science ®Google Scholar
• Liu L, Liang L, Yang C, Zhou Y, Chen Y. Extracellular vesicles of Fusobacterium nucleatum compromise intestinal barrier through targeting RIPK1-mediated cell death pathway. Gut Microbes. 2021;13(1):1–20. doi:10.1080/19490976.2021.1902718
   Web of Science ®Google Scholar
• Ma L, Shen Q, Lyu W, et al. Clostridium butyricum and its derived extracellular vesicles modulate gut homeostasis and ameliorate acute experimental colitis. Microbiol Spectr. 2022;10(4):e0136822. doi:10.1128/spectrum.01368-22
   PubMed Web of Science ®Google Scholar
• Yuan C, Burns MB, Subramanian S, Blekhman R, Sharpton T. Interaction between host MicroRNAs and the gut microbiota in colorectal cancer. mSystems. 2018;3(3). doi:10.1128/mSystems.00205-17
   Web of Science ®Google Scholar
• Ji Y, Li X, Zhu Y, et al. Faecal microRNA as a biomarker of the activity and prognosis of inflammatory bowel diseases. Biochem Biophys Res Commun. 2018;503(4):2443–2450. doi:10.1016/j.bbrc.2018.06.174
   PubMed Web of Science ®Google Scholar
• Bittel M, Reichert P, Sarfati I, et al. Visualizing transfer of microbial biomolecules by outer membrane vesicles in microbe-host-communication in vivo. J Extracell Vesicles. 2021;10(12):e12159. doi:10.1002/jev2.12159
   PubMed Web of Science ®Google Scholar
• Han Z, Peng X, Yang Y, et al. Integrated microfluidic-SERS for exosome biomarker profiling and osteosarcoma diagnosis. Biosens Bioelectron. 2022;217:114709. doi:10.1016/j.bios.2022.114709
   PubMed Web of Science ®Google Scholar
• Lee CH, Im EJ, Moon PG, Baek MC. Discovery of a diagnostic biomarker for colon cancer through proteomic profiling of small extracellular vesicles. BMC Cancer. 2018;18(1):1058. doi:10.1186/s12885-018-4952-y
   PubMedGoogle Scholar
• Fiandaca MS, Kapogiannis D, Mapstone M, et al. Identification of preclinical Alzheimer’s disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study. Alzheimers Dement. 2015;11(6):600–607.e601. doi:10.1016/j.jalz.2014.06.008
   PubMed Web of Science ®Google Scholar
• Taylor DD, Gercel-Taylor C. Retracted: microRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008;110(1):13–21. doi:10.1016/j.ygyno.2008.04.033
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105(30):10513–10518. doi:10.1073/pnas.0804549105
   PubMed Web of Science ®Google Scholar
• Xie L, Zhang Q, Mao J, Zhang J, Li L. The roles of lncRNA in myocardial infarction: molecular mechanisms, diagnosis biomarkers, and therapeutic perspectives. Front Cell Dev Biol. 2021;9:680713. doi:10.3389/fcell.2021.680713
   PubMed Web of Science ®Google Scholar
• Karimi N, Ali Hosseinpour Feizi M, Safaralizadeh R, et al. Serum overexpression of miR-301a and miR-23a in patients with colorectal cancer. J Chin Med Assoc. 2019;82(3):215–220. doi:10.1097/JCMA.0000000000000031
   PubMed Web of Science ®Google Scholar
• Fu F, Jiang W, Zhou L, Chen Z. Circulating exosomal miR-17-5p and miR-92a-3p predict pathologic stage and grade of colorectal cancer. Transl Oncol. 2018;11(2):221–232. doi:10.1016/j.tranon.2017.12.012
   PubMed Web of Science ®Google Scholar
• Wang YH, Ji J, Wang BC, et al. Tumor-derived exosomal long noncoding RNAs as promising diagnostic biomarkers for prostate cancer. Cell Physiol Biochem. 2018;46(2):532–545. doi:10.1159/000488620
   PubMed Web of Science ®Google Scholar
• Krug AK, Enderle D, Karlovich C, et al. Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma. Ann Oncol. 2018;29(10):2143. doi:10.1093/annonc/mdy261
   PubMed Web of Science ®Google Scholar
• Castellanos-Rizaldos E, Grimm DG, Tadigotla V, et al. Exosome-based detection of EGFR T790M in plasma from non-small cell lung cancer patients. Clin Cancer Res. 2018;24(12):2944–2950. doi:10.1158/1078-0432.CCR-17-3369
   PubMed Web of Science ®Google Scholar
• Zhu Y, Zhang H, Chen N, et al. Diagnostic value of various liquid biopsy methods for pancreatic cancer: a systematic review and meta-analysis. Medicine. 2020;99(3):e18581. doi:10.1097/MD.0000000000018581
   PubMed Web of Science ®Google Scholar
• Heo M, Park YS, Yoon H, et al. Potential of gut microbe-derived extracellular vesicles to differentiate inflammatory bowel disease patients from healthy controls. Gut Liver. 2023;17(1):108–118. doi:10.5009/gnl220081
   PubMed Web of Science ®Google Scholar
• Yoon H, Kim NE, Park J, et al. Analysis of the gut microbiome using extracellular vesicles in the urine of patients with colorectal cancer. Korean J Intern Med. 2023;38(1):27–38. doi:10.3904/kjim.2022.112
   PubMedGoogle Scholar
• Yang J, McDowell A, Seo H, et al. Diagnostic models for atopic dermatitis based on serum microbial extracellular vesicle metagenomic analysis: a Pilot Study. Allergy Asthma Immunol Res. 2020;12(5):792–805. doi:10.4168/aair.2020.12.5.792
   PubMed Web of Science ®Google Scholar
• Melo SA, Luecke LB, Kahlert C, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015;523(7559):177–182. doi:10.1038/nature14581
   PubMed Web of Science ®Google Scholar
• Sohn W, Kim J, Kang SH, et al. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma. Exp Mol Med. 2015;47(9):e184. doi:10.1038/emm.2015.68
   PubMed Web of Science ®Google Scholar
• Qiu X, Zhu H, Liu S, et al. Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer. J Gastroenterol Hepatol. 2017;32(4):819–827. doi:10.1111/jgh.13533
   PubMed Web of Science ®Google Scholar
• Wei C, Chen X, Ji J, et al. Urinary exosomal prostate-specific antigen is a noninvasive biomarker to detect prostate cancer: not only old wine in new bottles. Int J Cancer. 2023;152(8):1719–1727. doi:10.1002/ijc.34388
   PubMed Web of Science ®Google Scholar
• Kim JE, Eom JS, Kim WY, et al. Diagnostic value of microRNAs derived from exosomes in bronchoalveolar lavage fluid of early-stage lung adenocarcinoma: a pilot study. Thorac Cancer. 2018;9(8):911–915. doi:10.1111/1759-7714.12756
   PubMed Web of Science ®Google Scholar
• Shen X, Xue Y, Cong H, et al. Circulating lncRNA DANCR as a potential auxillary biomarker for the diagnosis and prognostic prediction of colorectal cancer. Biosci Rep. 2020;40(3). doi:10.1042/BSR20191481
   Google Scholar
• Liu CG, Song J, Zhang YQ, Wang PC. MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer’s disease. Mol Med Rep. 2014;10(5):2395–2400. doi:10.3892/mmr.2014.2484
   PubMed Web of Science ®Google Scholar
• Skriner K, Adolph K, Jungblut PR, Burmester GR. Association of citrullinated proteins with synovial exosomes. Arthritis Rheum. 2006;54(12):3809–3814. doi:10.1002/art.22276
   PubMed Web of Science ®Google Scholar
• Jiang H, Toscano JF, Song SS, et al. Author correction: differential expression of circulating exosomal microRNAs in refractory intracranial atherosclerosis associated with antiangiogenesis. Sci Rep. 2021;11(1):15266. doi:10.1038/s41598-021-94233-1
   PubMed Web of Science ®Google Scholar
• Hao S, Bai O, Li F, et al. Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunity. Immunology. 2007;120(1):90–102. doi:10.1111/j.1365-2567.2006.02483.x
   PubMed Web of Science ®Google Scholar
• Chen Z, Dehm S, Bonham K, et al. DNA array and biological characterization of the impact of the maturation status of mouse dendritic cells on their phenotype and antitumor vaccination efficacy. Cell Immunol. 2001;214(1):60–71. doi:10.1006/cimm.2001.1883
   PubMed Web of Science ®Google Scholar
• Seo N, Shirakura Y, Tahara Y, et al. Activated CD8(+) T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells. Nat Commun. 2018;9(1):435. doi:10.1038/s41467-018-02865-1
   PubMed Web of Science ®Google Scholar
• Jiang Y, Jiang H, Wang K, et al. Hypoxia enhances the production and antitumor effect of exosomes derived from natural killer cells. Ann Transl Med. 2021;9(6):473. doi:10.21037/atm-21-347
   PubMed Web of Science ®Google Scholar
• Wang X, Huang R, Lu Z, et al. Exosomes from M1-polarized macrophages promote apoptosis in lung adenocarcinoma via the miR-181a-5p/ETS1/STK16 axis. Cancer Sci. 2022;113(3):986–1001. doi:10.1111/cas.15268
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zheng Y, Zhu Y, et al. Docetaxel-loaded M1 macrophage-derived exosomes for a safe and efficient chemoimmunotherapy of breast cancer. J Nanobiotechnol. 2022;20(1):359. doi:10.1186/s12951-022-01526-2
   PubMed Web of Science ®Google Scholar
• Yang Y, Guo Z, Chen W, et al. M2 macrophage-derived exosomes promote angiogenesis and growth of pancreatic ductal adenocarcinoma by targeting E2F2. Mol Ther. 2021;29(3):1226–1238. doi:10.1016/j.ymthe.2020.11.024
   PubMed Web of Science ®Google Scholar
• Lan J, Sun L, Xu F, et al. M2 macrophage-derived exosomes promote cell migration and invasion in colon cancer. Cancer Res. 2019;79(1):146–158. doi:10.1158/0008-5472.CAN-18-0014
   PubMed Web of Science ®Google Scholar
• Li J, Xue H, Li T, et al. Exosomes derived from mesenchymal stem cells attenuate the progression of atherosclerosis in ApoE(-/-) mice via miR-let7 mediated infiltration and polarization of M2 macrophage. Biochem Biophys Res Commun. 2019;510(4):565–572. doi:10.1016/j.bbrc.2019.02.005
   PubMed Web of Science ®Google Scholar
• Zhang J, Rong Y, Luo C, Cui W. Bone marrow mesenchymal stem cell-derived exosomes prevent osteoarthritis by regulating synovial macrophage polarization. Aging. 2020;12(24):25138–25152. doi:10.18632/aging.104110
   PubMedGoogle Scholar
• Khare D, Or R, Resnick I, et al. Mesenchymal stromal cell-derived exosomes affect mRNA expression and function of B-lymphocytes. Front Immunol. 2018;9:3053. doi:10.3389/fimmu.2018.03053
   PubMed Web of Science ®Google Scholar
• Hu W, Song X, Yu H, Sun J, Zhao Y. Released exosomes contribute to the immune modulation of cord blood-derived stem cells. Front Immunol. 2020;11:165. doi:10.3389/fimmu.2020.00165
   PubMed Web of Science ®Google Scholar
• Reis M, Mavin E, Nicholson L, et al. Mesenchymal stromal cell-derived extracellular vesicles attenuate dendritic cell maturation and function. Front Immunol. 2018;9:2538. doi:10.3389/fimmu.2018.02538
   PubMed Web of Science ®Google Scholar
• Xia Q, Wang Q, Lin F, Wang J. miR-125a-5p-abundant exosomes derived from mesenchymal stem cells suppress chondrocyte degeneration via targeting E2F2 in traumatic osteoarthritis. Bioengineered. 2021;12(2):11225–11238. doi:10.1080/21655979.2021.1995580
   PubMed Web of Science ®Google Scholar
• Chen X, Shi Y, Xue P, et al. Mesenchymal stem cell-derived exosomal microRNA-136-5p inhibits chondrocyte degeneration in traumatic osteoarthritis by targeting ELF3. Arthritis Res Ther. 2020;22(1):256. doi:10.1186/s13075-020-02325-6
   PubMed Web of Science ®Google Scholar
• Bruno S, Tapparo M, Collino F, et al. Renal regenerative potential of different extracellular vesicle populations derived from bone marrow mesenchymal stromal cells. Tissue Eng Part A. 2017;23(21–22):1262–1273. doi:10.1089/ten.tea.2017.0069
   PubMed Web of Science ®Google Scholar
• Feng Y, Huang W, Wani M, Yu X, Ashraf M, Qin G. Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS One. 2014;9(2):e88685. doi:10.1371/journal.pone.0088685
   PubMed Web of Science ®Google Scholar
• Cai G, Cai G, Zhou H, et al. Retracted article: mesenchymal stem cell-derived exosome miR-542-3p suppresses inflammation and prevents cerebral infarction. Stem Cell Res Ther. 2021;12(1):2. doi:10.1186/s13287-020-02030-w
   PubMed Web of Science ®Google Scholar
• Nakano M, Kubota K, Kobayashi E, et al. Bone marrow-derived mesenchymal stem cells improve cognitive impairment in an Alzheimer’s disease model by increasing the expression of microRNA-146a in hippocampus. Sci Rep. 2020;10(1):10772. doi:10.1038/s41598-020-67460-1
   PubMed Web of Science ®Google Scholar
• Sengupta V, Sengupta S, Lazo A, et al. Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19. Stem Cells Dev. 2020;29(12):747–754. doi:10.1089/scd.2020.0080
   PubMed Web of Science ®Google Scholar
• Dai S, Wei D, Wu Z, et al. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther. 2008;16(4):782–790. doi:10.1038/mt.2008.1
   PubMed Web of Science ®Google Scholar
• Escudier B, Dorval T, Chaput N, et al. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial. J Transl Med. 2005;3(1):10. doi:10.1186/1479-5876-3-10
   PubMed Web of Science ®Google Scholar
• Besse B, Charrier M, Lapierre V, et al. Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. Oncoimmunology. 2016;5(4):e1071008. doi:10.1080/2162402X.2015.1071008
   PubMed Web of Science ®Google Scholar
• Nassar W, El-Ansary M, Sabry D, et al. Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases. Biomater Res. 2016;20(1):21. doi:10.1186/s40824-016-0068-0
   PubMedGoogle Scholar
• Sun D, Zhuang X, Xiang X, et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther. 2010;18(9):1606–1614. doi:10.1038/mt.2010.105
   PubMed Web of Science ®Google Scholar
• Wei H, Chen J, Wang S, et al. A nanodrug consisting of doxorubicin and exosome derived from mesenchymal stem cells for osteosarcoma treatment in vitro. Int J Nanomed. 2019;14:8603–8610. doi:10.2147/IJN.S218988
   PubMed Web of Science ®Google Scholar
• Pascucci L, Coccè V, Bonomi A, et al. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J Control Release. 2014;192:262–270. doi:10.1016/j.jconrel.2014.07.042
   PubMed Web of Science ®Google Scholar
• Alvarez-Erviti L, Seow Y, Yin H, et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29(4):341–345. doi:10.1038/nbt.1807
   PubMed Web of Science ®Google Scholar
• Yang T, Fogarty B, LaForge B, et al. Delivery of small interfering RNA to inhibit vascular endothelial growth factor in zebrafish using natural brain endothelia cell-secreted exosome nanovesicles for the treatment of brain cancer. AAPS J. 2017;19(2):475–486. doi:10.1208/s12248-016-0015-y
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang Y, Bai M, et al. Exosomes serve as nanoparticles to suppress tumor growth and angiogenesis in gastric cancer by delivering hepatocyte growth factor siRNA. Cancer Sci. 2018;109(3):629–641. doi:10.1111/cas.13488
   PubMed Web of Science ®Google Scholar
• Chen Z, Wang H, Xia Y, Yan F, Lu Y. Therapeutic potential of mesenchymal cell-derived miRNA-150-5p-expressing exosomes in rheumatoid arthritis mediated by the modulation of MMP14 and VEGF. J Immunol. 2018;201(8):2472–2482. doi:10.4049/jimmunol.1800304
   PubMed Web of Science ®Google Scholar
• Usman WM, Pham TC, Kwok YY, et al. Efficient RNA drug delivery using red blood cell extracellular vesicles. Nat Commun. 2018;9(1):2359. doi:10.1038/s41467-018-04791-8
   PubMed Web of Science ®Google Scholar
• Yang Z, Shi J, Xie J, et al. Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation. Nat Biomed Eng. 2020;4(1):69–83. doi:10.1038/s41551-019-0485-1
   PubMed Web of Science ®Google Scholar
• Haney MJ, Zhao Y, Harrison EB, et al. Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseases. PLoS One. 2013;8(4):e61852. doi:10.1371/journal.pone.0061852
   PubMed Web of Science ®Google Scholar
• Lamichhane TN, Raiker RS, Jay SM. Exogenous DNA loading into extracellular vesicles via electroporation is size-dependent and enables limited gene delivery. Mol Pharm. 2015;12(10):3650–3657. doi:10.1021/acs.molpharmaceut.5b00364
   PubMed Web of Science ®Google Scholar
• Qu M, Lin Q, Huang L, et al. Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson’s disease. J Control Release. 2018;287:156–166. doi:10.1016/j.jconrel.2018.08.035
   PubMed Web of Science ®Google Scholar
• Ovchinnikova LA, Terekhov SS, Ziganshin RH, et al. Reprogramming extracellular vesicles for protein therapeutics delivery. Pharmaceutics. 2021;13(6):768. doi:10.3390/pharmaceutics13060768
   PubMed Web of Science ®Google Scholar
• Haney MJ, Klyachko NL, Zhao Y, et al. Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Control Release. 2015;207:18–30. doi:10.1016/j.jconrel.2015.03.033
   PubMed Web of Science ®Google Scholar
• Fuhrmann G, Serio A, Mazo M, Nair R, Stevens MM. Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J Control Release. 2015;205:35–44. doi:10.1016/j.jconrel.2014.11.029
   PubMed Web of Science ®Google Scholar
• Kim MS, Haney MJ, Zhao Y, et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine. 2016;12(3):655–664. doi:10.1016/j.nano.2015.10.012
   PubMed Web of Science ®Google Scholar
• Salarpour S, Forootanfar H, Pournamdari M, et al. Paclitaxel incorporated exosomes derived from glioblastoma cells: comparative study of two loading techniques. Daru. 2019;27(2):533–539. doi:10.1007/s40199-019-00280-5
   PubMed Web of Science ®Google Scholar
• Kooijmans SAA, Stremersch S, Braeckmans K, et al. Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. J Control Release. 2013;172(1):229–238. doi:10.1016/j.jconrel.2013.08.014
   PubMed Web of Science ®Google Scholar
• Zhang H, Wu J, Wu J, et al. Exosome-mediated targeted delivery of miR-210 for angiogenic therapy after cerebral ischemia in mice. J Nanobiotechnol. 2019;17(1):29. doi:10.1186/s12951-019-0461-7
   PubMedGoogle Scholar
• Wang X, Chen Y, Zhao Z, et al. Engineered exosomes with ischemic myocardium-targeting peptide for targeted therapy in myocardial infarction. J Am Heart Assoc. 2018;7(15):e008737. doi:10.1161/JAHA.118.008737
   PubMed Web of Science ®Google Scholar
• Jia G, Han Y, An Y, et al. NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo. Biomaterials. 2018;178:302–316. doi:10.1016/j.biomaterials.2018.06.029
   PubMed Web of Science ®Google Scholar
• Tamura R, Uemoto S, Tabata Y. Augmented liver targeting of exosomes by surface modification with cationized pullulan. Acta Biomater. 2017;57:274–284. doi:10.1016/j.actbio.2017.05.013
   PubMed Web of Science ®Google Scholar
• Li Y, Gao Y, Gong C, et al. A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer. Nanomedicine. 2018;14(7):1973–1985. doi:10.1016/j.nano.2018.05.020
   PubMed Web of Science ®Google Scholar
• Qi H, Liu C, Long L, et al. Blood exosomes endowed with magnetic and targeting properties for cancer therapy. ACS Nano. 2016;10(3):3323–3333. doi:10.1021/acsnano.5b06939
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Teramura Y, Itagaki T, Arima Y, Iwata H. Interaction of poly(ethylene glycol)-conjugated phospholipids with supported lipid membranes and their influence on protein adsorption. Sci Technol Adv Mater. 2016;17(1):677–684. doi:10.1080/14686996.2016.1240006
   PubMed Web of Science ®Google Scholar
• Zhu L, Dong D, Yu Z-L, et al. Folate-engineered microvesicles for enhanced target and synergistic therapy toward breast cancer. ACS Appl Mater Interfaces. 2017;9(6):5100–5108. doi:10.1021/acsami.6b14633
   PubMed Web of Science ®Google Scholar
• Kooijmans SAA, Fliervoet LAL, van der Meel R, et al. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time. J Control Release. 2016;224:77–85. doi:10.1016/j.jconrel.2016.01.009
   PubMed Web of Science ®Google Scholar
• Lu J, Gao X, Wang S, et al. Advanced strategies to evade the mononuclear phagocyte system clearance of nanomaterials. Exploration. 2023;3(1):20220045. doi:10.1002/EXP.20220045
   Google Scholar
• Kooijmans SA, Aleza CG, Roffler SR, et al. Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting. J Extracell Vesicles. 2016;5(1):31053. doi:10.3402/jev.v5.31053
   PubMed Web of Science ®Google Scholar
• Liang G, Kan S, Zhu Y, et al. Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells. Int J Nanomed. 2018;13:585–599. doi:10.2147/IJN.S154458
   PubMed Web of Science ®Google Scholar
• Tian T, Cao L, He C, et al. Targeted delivery of neural progenitor cell-derived extracellular vesicles for anti-inflammation after cerebral ischemia. Theranostics. 2021;11(13):6507–6521. doi:10.7150/thno.56367
   PubMed Web of Science ®Google Scholar
• Matozaki T, Murata Y, Okazawa H, Ohnishi H. Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway. Trends Cell Biol. 2009;19(2):72–80. doi:10.1016/j.tcb.2008.12.001
   PubMed Web of Science ®Google Scholar
• Brown GC, Neher JJ. Eaten alive! Cell death by primary phagocytosis: ‘phagoptosis’. Trends Biochem Sci. 2012;37(8):325–332. doi:10.1016/j.tibs.2012.05.002
   PubMed Web of Science ®Google Scholar
• Parada N, Romero-Trujillo A, Georges N, Alcayaga-Miranda F. Camouflage strategies for therapeutic exosomes evasion from phagocytosis. J Adv Res. 2021;31:61–74. doi:10.1016/j.jare.2021.01.001
   PubMed Web of Science ®Google Scholar
• Du J, Wan Z, Wang C, et al. Designer exosomes for targeted and efficient ferroptosis induction in cancer via chemo-photodynamic therapy. Theranostics. 2021;11(17):8185–8196. doi:10.7150/thno.59121
   PubMed Web of Science ®Google Scholar
• Ramasubramanian L, Kumar P, Wang A. Engineering extracellular vesicles as nanotherapeutics for regenerative medicine. Biomolecules. 2019;10(1). doi:10.1021/acsanm.0c01553
   PubMed Web of Science ®Google Scholar
• Villata S, Canta M, Cauda V. EVs and bioengineering: from cellular products to engineered nanomachines. Int J Mol Sci. 2020;21(17). doi:10.3390/ijms21176048
   PubMed Web of Science ®Google Scholar
• Sato YT, Umezaki K, Sawada S, et al. Engineering hybrid exosomes by membrane fusion with liposomes. Sci Rep. 2016;6(1):21933. doi:10.1038/srep21933
   PubMed Web of Science ®Google Scholar
• Rayamajhi S, Nguyen TDT, Marasini R, Aryal S. Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery. Acta Biomater. 2019;94:482–494. doi:10.1016/j.actbio.2019.05.054
   PubMed Web of Science ®Google Scholar
• Mentkowski KI, Snitzer JD, Rusnak S, Lang JK. Therapeutic potential of engineered extracellular vesicles. AAPS J. 2018;20(3):50. doi:10.1208/s12248-018-0211-z
   PubMed Web of Science ®Google Scholar
• Lee JR, Park BW, Kim J, et al. Nanovesicles derived from iron oxide nanoparticles-incorporated mesenchymal stem cells for cardiac repair. Sci Adv. 2020;6(18):eaaz0952. doi:10.1126/sciadv.aaz0952
   PubMed Web of Science ®Google Scholar
• Altanerova U, Babincova M, Babinec P, et al. Human mesenchymal stem cell-derived iron oxide exosomes allow targeted ablation of tumor cells via magnetic hyperthermia. Int J Nanomed. 2017;12:7923–7936. doi:10.2147/IJN.S145096
   PubMed Web of Science ®Google Scholar
• Bull E, Madani SY, Sheth R, et al. Stem cell tracking using iron oxide nanoparticles. Int J Nanomed. 2014;9:1641–1653. doi:10.2147/IJN.S48979
   PubMed Web of Science ®Google Scholar
• Perets N, Betzer O, Shapira R, et al. Golden exosomes selectively target brain pathologies in neurodegenerative and neurodevelopmental disorders. Nano Lett. 2019;19(6):3422–3431. doi:10.1021/acs.nanolett.8b04148
   PubMed Web of Science ®Google Scholar
• Sancho-Albero M, Navascués N, Mendoza G, et al. Exosome origin determines cell targeting and the transfer of therapeutic nanoparticles towards target cells. J Nanobiotechnol. 2019;17(1):16. doi:10.1186/s12951-018-0437-z
   PubMedGoogle Scholar
• Cao Y, Wu T, Zhang K, et al. Engineered exosome-mediated near-infrared-II region V(2)C quantum dot delivery for nucleus-target low-temperature photothermal therapy. ACS Nano. 2019;13(2):1499–1510. doi:10.1021/acsnano.8b07224
   PubMed Web of Science ®Google Scholar
• Zhang M, Vojtech L, Ye Z, Hladik F, Nance E. Quantum dot labeling and visualization of extracellular vesicles. ACS Appl Nano Mater. 2020;3(7):7211–7222.
   PubMed Web of Science ®Google Scholar
• Di H, Zeng E, Zhang P, et al. General approach to engineering extracellular vesicles for biomedical analysis. Anal Chem. 2019;91(20):12752–12759. doi:10.1021/acs.analchem.9b02268
   PubMed Web of Science ®Google Scholar
• Sancho-Albero M, Encabo-Berzosa MDM, Beltrán-Visiedo M, et al. Efficient encapsulation of theranostic nanoparticles in cell-derived exosomes: leveraging the exosomal biogenesis pathway to obtain hollow gold nanoparticle-hybrids. Nanoscale. 2019;11(40):18825–18836. doi:10.1039/C9NR06183E
   PubMed Web of Science ®Google Scholar
• Poongodi R, Chen YL, Yang TH, et al. Bio-scaffolds as cell or exosome carriers for nerve injury repair. Int J Mol Sci. 2021;22(24):13347. doi:10.3390/ijms222413347
   PubMed Web of Science ®Google Scholar
• Rowland CR, Glass KA, Ettyreddy AR, et al. Regulation of decellularized tissue remodeling via scaffold-mediated lentiviral delivery in anatomically-shaped osteochondral constructs. Biomaterials. 2018;177:161–175. doi:10.1016/j.biomaterials.2018.04.049
   PubMed Web of Science ®Google Scholar
• Jiang S, Tian G, Yang Z, et al. Enhancement of acellular cartilage matrix scaffold by Wharton’s jelly mesenchymal stem cell-derived exosomes to promote osteochondral regeneration. Bioact Mater. 2021;6(9):2711–2728. doi:10.1016/j.bioactmat.2021.01.031
   PubMed Web of Science ®Google Scholar
• Tsou YH, Khoneisser J, Huang PC, Xu X. Hydrogel as a bioactive material to regulate stem cell fate. Bioact Mater. 2016;1(1):39–55. doi:10.1016/j.bioactmat.2016.05.001
   PubMedGoogle Scholar
• Ju Y, Hu Y, Yang P, Xie X, Fang B. Extracellular vesicle-loaded hydrogels for tissue repair and regeneration. Mater Today Bio. 2023;18:100522. doi:10.1016/j.mtbio.2022.100522
   PubMedGoogle Scholar
• Zhou Y, Zhang XL, Lu ST, et al. Human adipose-derived mesenchymal stem cells-derived exosomes encapsulated in pluronic F127 hydrogel promote wound healing and regeneration. Stem Cell Res Ther. 2022;13(1):407. doi:10.1186/s13287-022-02980-3
   PubMed Web of Science ®Google Scholar
• Lu W, Zeng M, Liu W, et al. Human urine-derived stem cell exosomes delivered via injectable GelMA templated hydrogel accelerate bone regeneration. Mater Today Bio. 2023;19:100569. doi:10.1016/j.mtbio.2023.100569
   PubMedGoogle Scholar
• Hu H, Dong L, Bu Z, et al. miR-23a-3p-abundant small extracellular vesicles released from Gelma/nanoclay hydrogel for cartilage regeneration. J Extracell Vesicles. 2020;9(1):1778883. doi:10.1080/20013078.2020.1778883
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang J, Cheng X, et al. Integrated printed BDNF-stimulated HUCMSCs-derived exosomes/collagen/chitosan biological scaffolds with 3D printing technology promoted the remodelling of neural networks after traumatic brain injury. Regen Biomater. 2023;10:rbac085. doi:10.1093/rb/rbac085
   PubMed Web of Science ®Google Scholar
• Thakur S, Anjum MM, Jaiswal S, et al. Novel synergistic approach: tazarotene-calcipotriol-loaded-PVA/PVP-nanofibers incorporated in hydrogel film for management and treatment of psoriasis. Mol Pharm. 2023;20(2):997–1014. doi:10.1021/acs.molpharmaceut.2c00713
   PubMedGoogle Scholar
• Li M, Wu Y, Li H, et al. Nanofiber reinforced alginate hydrogel for leak-proof delivery and higher stress loading in nucleus pulposus. Carbohydr Polym. 2023;299:120193. doi:10.1016/j.carbpol.2022.120193
   PubMed Web of Science ®Google Scholar
• Zhou Y, Liu S, Zhao M, et al. Injectable extracellular vesicle-released self-assembling peptide nanofiber hydrogel as an enhanced cell-free therapy for tissue regeneration. J Control Release. 2019;316:93–104. doi:10.1016/j.jconrel.2019.11.003
   PubMed Web of Science ®Google Scholar
• Smith LA, Liu X, Ma PX. Tissue engineering with nano-fibrous scaffolds. Soft Matter. 2008;4(11):2144–2149. doi:10.1039/b807088c
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Nishikawa M, Shinotsuka H, et al. Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J Biotechnol. 2013;165(2):77–84. doi:10.1016/j.jbiotec.2013.03.013
   PubMed Web of Science ®Google Scholar
• Gangadaran P, Li XJ, Lee HW, et al. A new bioluminescent reporter system to study the biodistribution of systematically injected tumor-derived bioluminescent extracellular vesicles in mice. Oncotarget. 2017;8(66):109894–109914. doi:10.18632/oncotarget.22493
   PubMedGoogle Scholar
• Faruqu FN, Wang JT, Xu L, et al. Membrane radiolabelling of exosomes for comparative biodistribution analysis in immunocompetent and immunodeficient mice - a novel and universal approach. Theranostics. 2019;9(6):1666–1682. doi:10.7150/thno.27891
   PubMed Web of Science ®Google Scholar
• Rashid MH, Borin TF, Ara R, et al. Differential in vivo biodistribution of (131)I-labeled exosomes from diverse cellular origins and its implication for theranostic application. Nanomedicine. 2019;21:102072. doi:10.1016/j.nano.2019.102072
   PubMed Web of Science ®Google Scholar
• Hwang DW, Choi H, Jang SC, et al. Noninvasive imaging of radiolabeled exosome-mimetic nanovesicle using (99m)Tc-HMPAO. Sci Rep. 2015;5:15636. doi:10.1038/srep15636
   PubMed Web of Science ®Google Scholar
• Hu L, Wickline SA, Hood JL. Magnetic resonance imaging of melanoma exosomes in lymph nodes. Magn Reson Med. 2015;74(1):266–271. doi:10.1002/mrm.25376
   PubMed Web of Science ®Google Scholar
• Busato A, Bonafede R, Bontempi P, et al. Magnetic resonance imaging of ultrasmall superparamagnetic iron oxide-labeled exosomes from stem cells: a new method to obtain labeled exosomes. Int J Nanomed. 2016;11:2481–2490. doi:10.2147/IJN.S104152
   PubMed Web of Science ®Google Scholar
• Zhang M, Xiao B, Wang H, et al. Edible ginger-derived nano-lipids loaded with doxorubicin as a novel drug-delivery approach for colon cancer therapy. Mol Ther. 2016;24(10):1783–1796. doi:10.1038/mt.2016.159
   PubMed Web of Science ®Google Scholar
• Zhuang X, Teng Y, Samykutty A, et al. Grapefruit-derived nanovectors delivering therapeutic miR17 through an intranasal route inhibit brain tumor progression. Mol Ther. 2016;24(1):96–105. doi:10.1038/mt.2015.188
   PubMed Web of Science ®Google Scholar
• Liu J, Xiang J, Jin C, et al. Medicinal plant-derived mtDNA via nanovesicles induces the cGAS-STING pathway to remold tumor-associated macrophages for tumor regression. J Nanobiotechnology. 2023;21(1):78. doi:10.1186/s12951-023-01835-0
   PubMed Web of Science ®Google Scholar
• Chen X, Zhou Y, Yu J. Exosome-like nanoparticles from ginger rhizomes inhibited NLRP3 inflammasome activation. Mol Pharm. 2019;16(6):2690–2699. doi:10.1021/acs.molpharmaceut.9b00246
   PubMedGoogle Scholar
• Liu B, Lu Y, Chen X, et al. Protective role of shiitake mushroom-derived exosome-like nanoparticles in D-galactosamine and lipopolysaccharide-induced acute liver injury in mice. Nutrients. 2020;12(2):477.
   PubMed Web of Science ®Google Scholar
• Zhang M, Viennois E, Prasad M, et al. Edible ginger-derived nanoparticles: a novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials. 2016;101:321–340. doi:10.1016/j.biomaterials.2016.06.018
   PubMed Web of Science ®Google Scholar
• Teng Y, Ren Y, Sayed M, et al. Plant-derived exosomal MicroRNAs shape the gut microbiota. Cell Host Microbe. 2018;24(5):637–652.e638. doi:10.1016/j.chom.2018.10.001
   PubMed Web of Science ®Google Scholar
• Chen Q, Li Q, Liang Y, et al. Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation. Acta Pharm Sin B. 2022;12(2):907–923. doi:10.1016/j.apsb.2021.08.016
   PubMed Web of Science ®Google Scholar
• Yepes-Molina L, Carvajal M. Nanoencapsulation of sulforaphane in broccoli membrane vesicles and their in vitro antiproliferative activity. Pharm Biol. 2021;59(1):1490–1504. doi:10.1080/13880209.2021.1992450
   PubMed Web of Science ®Google Scholar
• Xu Z, Huang H, Xiong X, et al. A near-infrared light-responsive extracellular vesicle as a “Trojan horse” for tumor deep penetration and imaging-guided therapy. Biomaterials. 2021;269:120647. doi:10.1016/j.biomaterials.2020.120647
   PubMed Web of Science ®Google Scholar
• Zhang Q, Xiao Q, Yin H, et al. Milk-exosome based pH/light sensitive drug system to enhance anticancer activity against oral squamous cell carcinoma. RSC Adv. 2020;10(47):28314–28323. doi:10.1039/D0RA05630H
   PubMed Web of Science ®Google Scholar
• Nie W, Wu G, Zhang J, et al. Responsive exosome nano-bioconjugates for synergistic cancer therapy. Angew Chem Int Ed Engl. 2020;59(5):2018–2022. doi:10.1002/anie.201912524
   PubMed Web of Science ®Google Scholar